Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

VivoSim Labs, Inc. (VIVS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

VivoSim Labs, Inc. (VIVS), most recent 12 months reported: revenue $112K, net loss $12.34M, free cash flow -$10.12M. Latest balance sheet on file: liquid cash $1.67M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): ProKidney Corp. · ImageneBio, Inc. · CARDIFF ONCOLOGY, INC. · aTYR PHARMA INC · AIM ImmunoTech Inc. · INMUNE BIO INC. · Senti Biosciences Holdings, Inc. · Creative Medical Technology Holdings, Inc.

Stock screener

Watchlist